Fundraising Fox
Syantra
Calgary, CA · 4 known investors
Find your way into Syantra
Sign up to see every warm intro you have to Syantra
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Syantra team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Syantra develops the patent-pending Onco-ID platform for early cancer detection, using a biomarker and drug target discovery technology to support oncologists and pharmaceutical scientists in creating personalized, precision cancer treatments. Founded from research at the University of Calgary, it serves the oncology diagnostics and precision medicine market.
Founders & leadership
TR
Tina RinkerCo-founder
KF
Ken FuhCo-founder
RM
Randy MooreCo-founderRandy Moore is a Professor of Surgery at the University of Calgary with over three decades of healthcare experience, including leadership roles as Chief Medical Officer at ViTAA Medical Solutions and Medical Director at Syantra, where he brings expertise in vascular surgery to the development of precision medicine solutions.
BS
Bob ShepherdCo-founder
Investors · 4
Funding
SEC filings, press & company announcements$3.6M disclosed across 1 round · 2024
- $3.6MSeries A-1Sep 2024 · 5 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 4
NateraNatera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.
FoxbusinessFOX Business Network is a financial news channel that delivers real-time business and market information across multiple platforms. The network serves investors and business audiences interested in news affecting both retail and institutional markets.
Outcomes4MeOutcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information. The platform serves cancer patients directly by offering decision support tools and health data management to improve treatment access and outcomes.
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Companies working in the same space as Syantra.
In the news
Frequently asked questions
- What does Syantra do?
- Syantra develops the patent-pending Onco-ID platform for early cancer detection, using a biomarker and drug target discovery technology to support oncologists and pharmaceutical scientists in creating personalized, precision cancer treatments. Founded from research at the University of Calgary, it serves the oncology diagnostics and precision medicine market.
- Who founded Syantra?
- Syantra was founded by Tina Rinker, Ken Fuh, Randy Moore, Bob Shepherd.
- Who are Syantra's investors?
- Syantra's investors include Plug and Play Ventures, The 51 Ventures, Thin Air Labs, UCeed Funds.
- How much funding has Syantra raised?
- Syantra has disclosed $3.6M raised across 1 round.
- Where is Syantra headquartered?
- Syantra is headquartered in Calgary, CA.